Preoperative prediction of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced golden-angle radial sparse parallel dynamic MRI.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
96 patients (9 females; mean age 57.
I · Intervention 중재 / 시술
gadoxetic acid-enhanced GRASP dynamic MRI
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] Gadoxetic acid-enhanced quantitative GRASP dynamic MRI reflects the hemodynamic changes associated with MVI. The integration of these quantitative parameters with clinicoradiographic features improved preoperative MVI prediction, demonstrating their potential clinical value.
[PURPOSE] To investigate the predictive value of preoperative gadoxetic acid-enhanced quantitative golden-angle radial sparse parallel (GRASP) dynamic MRI for microvascular invasion (MVI) status in he
- p-value p = 0.02
- p-value p = 0.04
APA
Chen M, Yan Z, et al. (2025). Preoperative prediction of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced golden-angle radial sparse parallel dynamic MRI.. European journal of radiology, 192, 112399. https://doi.org/10.1016/j.ejrad.2025.112399
MLA
Chen M, et al.. "Preoperative prediction of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced golden-angle radial sparse parallel dynamic MRI.." European journal of radiology, vol. 192, 2025, pp. 112399.
PMID
40902439 ↗
Abstract 한글 요약
[PURPOSE] To investigate the predictive value of preoperative gadoxetic acid-enhanced quantitative golden-angle radial sparse parallel (GRASP) dynamic MRI for microvascular invasion (MVI) status in hepatocellular carcinoma (HCC).
[METHODS] This single-institution prospective study included patients with suspected HCC who underwent gadoxetic acid-enhanced GRASP dynamic MRI. Quantitative parameters derived from dynamic MRI of tumor and peritumoral regions, along with clinical and conventional radiological features, were collected. Univariate analysis, LASSO regression and multivariate logistic regression were used to identify independent MVI predictors. Three models were developed: dynamic contrast-enhanced MRI (DCE-MRI), clinicoradiographic, and integrated, and validated using 5-fold stratified cross-validation. The models were evaluated using performance metrics, clinical decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
[RESULTS] 96 patients (9 females; mean age 57.41 ± 11.07 years) with pathologically confirmed HCC were enrolled, including 35 MVI-positive cases. Univariate analysis revealed significant associations between MVI and DCE-MRI parameters, including extracellular volume, uptake fraction, uptake rate, and arterial delay of tumor. Extracellular volume and uptake rate of tumor, apparent diffusion coefficient (ADC), and α-fetoprotein were identified as independent MVI predictors. Incorporating DCE-MRI into clinicoradiographic model significantly improved the AUC from 0.669 to 0.817 (p = 0.02), with increased NRI (0.336, p = 0.04) and IDI (0.215, p = 0.002). The DCA shows that the integrated model had the highest net profit rate.
[CONCLUSIONS] Gadoxetic acid-enhanced quantitative GRASP dynamic MRI reflects the hemodynamic changes associated with MVI. The integration of these quantitative parameters with clinicoradiographic features improved preoperative MVI prediction, demonstrating their potential clinical value.
[METHODS] This single-institution prospective study included patients with suspected HCC who underwent gadoxetic acid-enhanced GRASP dynamic MRI. Quantitative parameters derived from dynamic MRI of tumor and peritumoral regions, along with clinical and conventional radiological features, were collected. Univariate analysis, LASSO regression and multivariate logistic regression were used to identify independent MVI predictors. Three models were developed: dynamic contrast-enhanced MRI (DCE-MRI), clinicoradiographic, and integrated, and validated using 5-fold stratified cross-validation. The models were evaluated using performance metrics, clinical decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
[RESULTS] 96 patients (9 females; mean age 57.41 ± 11.07 years) with pathologically confirmed HCC were enrolled, including 35 MVI-positive cases. Univariate analysis revealed significant associations between MVI and DCE-MRI parameters, including extracellular volume, uptake fraction, uptake rate, and arterial delay of tumor. Extracellular volume and uptake rate of tumor, apparent diffusion coefficient (ADC), and α-fetoprotein were identified as independent MVI predictors. Incorporating DCE-MRI into clinicoradiographic model significantly improved the AUC from 0.669 to 0.817 (p = 0.02), with increased NRI (0.336, p = 0.04) and IDI (0.215, p = 0.002). The DCA shows that the integrated model had the highest net profit rate.
[CONCLUSIONS] Gadoxetic acid-enhanced quantitative GRASP dynamic MRI reflects the hemodynamic changes associated with MVI. The integration of these quantitative parameters with clinicoradiographic features improved preoperative MVI prediction, demonstrating their potential clinical value.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Liver Neoplasms
- Female
- Male
- Carcinoma
- Hepatocellular
- Gadolinium DTPA
- Middle Aged
- Contrast Media
- Magnetic Resonance Imaging
- Neoplasm Invasiveness
- Prospective Studies
- Microvessels
- Aged
- Preoperative Care
- Reproducibility of Results
- Sensitivity and Specificity
- Predictive Value of Tests
- Image Enhancement
- Contrast media
- Hepatocellular carcinoma
- Multiparametric magnetic resonance imaging
- Neoplasm invasion
같은 제1저자의 인용 많은 논문 (5)
- A radio-genomics biomarker for precision epidermal growth factor receptor mutation targeting therapy in non-small cell lung cancer.
- SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia.
- Artificial intelligence in colon cancer: A commentary on advances and challenges.
- Spatial blueprint of colorectal cancer identifies Hypoxic CAF program that orchestrates Go-or-Grow decisions and predicts outcomes.
- Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.